by In2Pharma | Jun 21, 2022 | News
Belgium In the context of the transparency policy conducted by the FAMHP, the FAMHP announced thematic audits starting from March 2022 at wholesalers in medicines for human use. These inspections will be unannounced. The inspections will focus on the obligations of...
by In2Pharma | Feb 12, 2018 | News
FAMHP It is not allowed for Wholesaler’s Distribution Authorization (WDA) holders to purchase medicines from companies based outside the European Economic Area (EEA) if these medicines were manufactured within the EEA and released by the qualified person of the...
